StonvexLoading…
StonvexStonvexStonvexCore line items from LLY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $19.80B | $65.18B | $45.89B | $28.29B |
Operating Income | $8.85B | $25.73B | $17.46B | $10.23B |
Net Income | $7.40B | $20.64B | $14.00B | $8.42B |
EPS (Diluted) | $8.26 | $22.95 | $15.56 | $9.35 |
Total Assets | $116.58B | $112.48B | $114.94B | $100.92B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.28B | $7.27B | $9.79B | $3.38B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 895.90M | 899.30M | 899.70M | 900.20M |